Literature DB >> 30955352

Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association.

Susan C Gilchrist, Ana Barac, Philip A Ades, Catherine M Alfano, Barry A Franklin, Lee W Jones, Andre La Gerche, Jennifer A Ligibel, Gabriel Lopez, Kushal Madan, Kevin C Oeffinger, Jeannine Salamone, Jessica M Scott, Ray W Squires, Randal J Thomas, Diane J Treat-Jacobson, Janet S Wright.   

Abstract

Cardiovascular disease is a competing cause of death in patients with cancer with early-stage disease. This elevated cardiovascular disease risk is thought to derive from both the direct effects of cancer therapies and the accumulation of risk factors such as hypertension, weight gain, cigarette smoking, and loss of cardiorespiratory fitness. Effective and viable strategies are needed to mitigate cardiovascular disease risk in this population; a multimodal model such as cardiac rehabilitation may be a potential solution. This statement from the American Heart Association provides an overview of the existing knowledge and rationale for the use of cardiac rehabilitation to provide structured exercise and ancillary services to cancer patients and survivors. This document introduces the concept of cardio-oncology rehabilitation, which includes identification of patients with cancer at high risk for cardiac dysfunction and a description of the cardiac rehabilitation infrastructure needed to address the unique exposures and complications related to cancer care. In this statement, we also discuss the need for future research to fully implement a multimodal model of cardiac rehabilitation for patients with cancer and to determine whether reimbursement of these services is clinically warranted.

Entities:  

Keywords:  AHA Scientific Statements; cancer; cardiac rehabilitation; cardiovascular diseases

Mesh:

Year:  2019        PMID: 30955352     DOI: 10.1161/CIR.0000000000000679

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  60 in total

Review 1.  Mechanobiology Assays with Applications in Cardiomyocyte Biology and Cardiotoxicity.

Authors:  Cheavar A Blair; Beth L Pruitt
Journal:  Adv Healthc Mater       Date:  2020-04-09       Impact factor: 9.933

Review 2.  Mechanisms of anthracycline-mediated cardiotoxicity and preventative strategies in women with breast cancer.

Authors:  Sonu S Varghese; Cameron R Eekhoudt; Davinder S Jassal
Journal:  Mol Cell Biochem       Date:  2021-04-09       Impact factor: 3.396

3.  NCCN Guidelines Insights: Survivorship, Version 2.2020.

Authors:  Crystal S Denlinger; Tara Sanft; Javid J Moslehi; Linda Overholser; Saro Armenian; K Scott Baker; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Norah Lynn Henry; Christine Hill-Kayser; Melissa Hudson; Nazanin Khakpour; Divya Koura; Allison L McDonough; Michelle Melisko; Kathi Mooney; Halle C F Moore; Natalie Moryl; Tracey O'Connor; Electra D Paskett; Chirayu Patel; Lindsay Peterson; William Pirl; M Alma Rodriguez; Kathryn J Ruddy; Lillie Shockney; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2020-08       Impact factor: 11.908

Review 4.  The cancer patient and cardiology.

Authors:  José Luis Zamorano; Christer Gottfridsson; Riccardo Asteggiano; Dan Atar; Lina Badimon; Jeroen J Bax; Daniela Cardinale; Antonella Cardone; Elizabeth A M Feijen; Péter Ferdinandy; Teresa López-Fernández; Chris P Gale; John H Maduro; Javid Moslehi; Torbjørn Omland; Juan Carlos Plana Gomez; Jessica Scott; Thomas M Suter; Giorgio Minotti
Journal:  Eur J Heart Fail       Date:  2020-10-02       Impact factor: 15.534

5.  Effects of an exercise-based oncology rehabilitation program and age on strength and physical function in cancer survivors.

Authors:  Kim Dittus; Michael Toth; Jeff Priest; Patricia O'Brien; Nathan Kokinda; Philip Ades
Journal:  Support Care Cancer       Date:  2019-12-11       Impact factor: 3.603

6.  Effect of neuromuscular electrical stimulation on skeletal muscle size and function in patients with breast cancer receiving chemotherapy.

Authors:  Michael J Toth; Thomas B Voigt; Timothy W Tourville; Shannon M Prior; Blas A Guigni; Axel V Schlosberg; Isaac B Smith; Taylor J Forest; Peter A Kaufman; Marie E Wood; Hibba Rehman; Kim Dittus
Journal:  J Appl Physiol (1985)       Date:  2020-05-07

7.  Cardiac Rehabilitation Programs for Cancer Survivors: A Scoping Review.

Authors:  Carmen C Cuthbertson; Emily E Pearce; Carmina G Valle; Kelly R Evenson
Journal:  Curr Epidemiol Rep       Date:  2020-05-08

Review 8.  Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-30       Impact factor: 32.419

Review 9.  Cardiovascular Complications Associated with Contemporary Lung Cancer Treatments.

Authors:  Kazuhiro Sase; Yasuhito Fujisaka; Masaaki Shoji; Mikio Mukai
Journal:  Curr Treat Options Oncol       Date:  2021-06-10

Review 10.  Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.

Authors:  Michael G Fradley; Theresa M Beckie; Sherry Ann Brown; Richard K Cheng; Susan F Dent; Anju Nohria; Kristen K Patton; Jagmeet P Singh; Brian Olshansky
Journal:  Circulation       Date:  2021-06-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.